Owner KAKEN PHARMACEUTICAL CO., LTD.

Inventors HARADA, Tatsuhiro; HAINO, Makoto; OKUYAMA, Akihiko; ARAKAWA, Yoshio; MURAKAMI, Yoshiko; SHIMANO, Masanao; KAMEI, Noriyuki; TANAKA, Tomohiro

Pub. Number AU-A-2002332299

PCT Number PCT/JP02/09036

PCT Pub. Number WO2003/022801

Priority 2001-272527 07.09.01 JP

Filing date 5 September 2002

Wipo publication date 24 March 2003

C07C 317/40 Sulfones

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/113 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 031/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 031/47 - Quinolines

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 001/14 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 003/10 Drugs for disorders of the metabolism

A61P 007/06 Drugs for disorders of the blood or the extracellular fluid

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 011/02 Drugs for disorders of the respiratory system

A61P 011/06 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

A61P 017/00 Drugs for dermatological disorders

A61P 019/02 Drugs for skeletal disorders

A61P 019/08 Drugs for skeletal disorders

A61P 021/00 Drugs for disorders of the muscular or neuromuscular system

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 035/00 Antineoplastic agents

A61P 037/00 Drugs for immunological or allergic disorders

A61P 037/08 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/14 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 317/72 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms